GLENMARK PHARMACEUTICALS EUROPE LIMITED
Reference: GB-COH-05040260
5
Awards
€47,262,345
Total awarded
Recent awards
- NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18
- Generic, Branded Generic & Proprietary Medicinal Products - Group 14
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.